(sorry for the late-in-the-day post. my present schedule is causing some delays in my usual daily routine)
I've posted about Sickle Cell Anemia treatments before, including the path to a possible cure for the disease. Today's post is about Hydroxea, a drug some doctors are reluctant to prescribe simply because they lack sufficient information about it.
"We know that many people with sickle cell disease aren't being offered this drug, which is the only one we have to treat this disease," says Sophie Lanzkron, M.D., assistant professor of medicine and oncology at the Johns Hopkins University School of Medicine and director of the Sickle Cell Center for Adults at Johns Hopkins.
There's some interesting research to back up Lanzkron's statement. The Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services, paid for that research. Read about it HERE and be sure to share the findings with relevant medical professionals.
Find out how to search for and how to contact the medical professional you need when you read my book. It's all about Patient Empowerment.
- By the way, I APPRECIATE your votes for my various blogposts (I installed that starred widget thingy just last week, even though it appears on every page of this year-or-so old blog). Feedback from YOU makes my day! If you don't mind, let me also know why you've bought my book. Sales rose sharply this month and I'm curious to know why it's selling so briskly just now.
Coping with a Medical Crisis?
Make the Changes You Need in Your Life.